EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause and Cause-Specific Mortality

Rosa Oh, Seohyun Kim, So Hyun Cho, Jiyoon Kim, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Gyuri Kim, Jae Hyeon Kim

Diabetes & Metabolism Journal · 01.01.2025 · 49 (1) · 80-91

DOI: 10.4093/dmj.2024.0042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes & Metabolism Journal, erschienen am 01.01.2025. Verfasst von Rosa Oh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Metabolic Diseases, Fatty Liver. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Given the association between nonalcoholic fatty liver disease and metabolic risks, a new term, metabolic dysfunction- associated steatotic liver disease (MASLD) has been proposed. We aimed to explore the association between MASLD and all-cause, cause-specific mortalities.

Methods

We included individuals with steatotic liver disease (SLD) from the Korean National Health Insurance Service. Moreover, SLD was defined as a fatty liver index ≥30. Furthermore, MASLD, metabolic alcohol-associated liver disease (MetALD), and alcoholic liver disease (ALD) with metabolic dysfunction (MD) were categorized based on alcohol consumption and MD. We also analyzed all-cause, liver-, cancer-, hepatocellular carcinoma (HCC)- and cardiovascular (CV)-related mortalities.

Results

This retrospective nationwide cohort study included 1,298,993 individuals aged 40 to 79 years for a mean follow-up duration of 9.04 years. The prevalence of MASLD, MetALD, and ALD with MD was 33.11%, 3.93%, and 1.00%, respectively. Relative to the “no SLD” group, multivariable analysis identified that MASLD (adjusted hazard ratio [aHR], 1.28; 95% confidence interval [CI], 1.26 to 1.31), MetALD (aHR, 1.38; 95% CI, 1.32 to 1.44), and ALD with MD group (aHR, 1.80; 95% CI, 1.68 to 1.93) have a significantly higher risk of all-cause mortality. Furthermore, MASLD, MetALD, ALD with MD groups showed higher liver-, cancer-, and HCC-related mortality than “no SLD” group. While all-cause specific mortalities increase from MASLD to MetALD to ALD with MD, the MetALD group shows a lower risk of CV-related mortality compared to MASLD. However, ALD with MD group still have a higher risk of CV-related mortality compared to MASLD.

Conclusion

SLD is associated with an increased risk of all-cause, liver-, cancer-, HCC-, and CV-related mortalities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseMetabolic DiseasesFatty LiverHumansMiddle AgedMaleFemaleRetrospective StudiesAdultAgedRepublic of KoreaCause of DeathLiver NeoplasmsRisk FactorsCarcinoma, HepatocellularPrevalenceCardiovascular DiseasesLiver Diseases, Alcoholic

Stichwörter der Autor:innen

Fatty liverMetabolic syndromeMortality

Autor:innen und Institutionen

  • Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences and Technology (SAIHST), Sungkyunkwan University, Seoul, Korea.

Zitieren

APA

Oh, R., Kim, S., Cho, S. H., Kim, J., Lee, Y. B., Jin, S. M., Hur, K. Y., Kim, G., & Kim, J. H. (2025). Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause and Cause-Specific Mortality. Diabetes & Metabolism Journal, 49(1), 80-91. https://doi.org/10.4093/dmj.2024.0042

Vancouver

Oh R, Kim S, Cho SH, Kim J, Lee YB, Jin SM, et al. Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause and Cause-Specific Mortality. Diabetes & Metabolism Journal. 2025;49(1):80-91. doi:10.4093/dmj.2024.0042

BibTeX
@article{Oh2025,
  author = {Oh, Rosa and Kim, Seohyun and Cho, So Hyun and Kim, Jiyoon and Lee, You-Bin and Jin, Sang-Man and Hur, Kyu Yeon and Kim, Gyuri and Kim, Jae Hyeon},
  title = {Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause and Cause-Specific Mortality},
  journal = {Diabetes & Metabolism Journal},
  year = {2025},
  volume = {49},
  number = {1},
  pages = {80--91},
  doi = {10.4093/dmj.2024.0042}
}
Kostenlos starten →